-
Je něco špatně v tomto záznamu ?
Combined effect of lasioglossin LL-III derivative with azoles against Candida albicans virulence factors: biofilm formation, phospholipases, proteases and hemolytic activity
E. Vaňková, P. Kašparová, N. Dulíčková, V. Čeřovský
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NV16-27726A
MZ0
CEP - Centrální evidence projektů
Digitální knihovna NLK
Plný text - Článek
NLK
PubMed Central
od 2015
ProQuest Central
od 2003-03-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2003-03-01 do Před 1 rokem
Oxford Journals Open Access Collection
od 2001-04-01
PubMed
32324227
DOI
10.1093/femsyr/foaa020
Knihovny.cz E-zdroje
- MeSH
- antifungální látky farmakologie MeSH
- azoly farmakologie MeSH
- biofilmy účinky léků růst a vývoj MeSH
- Candida albicans účinky léků MeSH
- erytrocyty účinky léků MeSH
- faktory virulence MeSH
- fosfolipasy antagonisté a inhibitory MeSH
- hemolýza účinky léků MeSH
- hydrofobní a hydrofilní interakce účinky léků MeSH
- kationické antimikrobiální peptidy chemická syntéza farmakokinetika MeSH
- lidé MeSH
- proteasy metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Candida albicans has several virulence factors at its disposal, including yeast-hyphal transition associated with biofilm formation, phospholipases, proteases and hemolytic activity, all of which contribute to its pathogenesis. We used synthetic derivative LL-III/43 of antimicrobial peptide lasioglossin LL-III to enhance effect of azoles on attenuation of C. albicans virulence factors. LL-III/43 was able to inhibit initial adhesion or biofilm formation of C. albicans strains at 50 µM. Azoles, however, were ineffective at this concentration. Using fluorescently labeled LL-III/43, we observed that peptide covered C. albicans cells, partially penetrated through their membranes and then accumulated inside cells. LL-III/43 (25 µM) in combination with clotrimazole prevented biofilm formation already at 3.1 µM clotrimazole. Neither LL-III/43 nor azoles were able to significantly inhibit phospholipases, proteases, or hemolytic activity of C. albicans. LL-III/43 (25 µM) and clotrimazole (50 µM) in combination decreased production of these virulence factors, and it completely attenuated its hemolytic activity. Scanning electron microscopy showed that LL-III/43 (50 µM) prevented C. albicans biofilm formation on Ti-6Al-4 V alloy used in orthopedic surgeries and combination of LL-III/43 (25 µM) with clotrimazole (3.1 µM) prevented biofilm formation on urinary catheters. Therefore, mixture of LL-III/43 and clotrimazole is suitable candidate for future pharmaceutical research.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026713
- 003
- CZ-PrNML
- 005
- 20211026132700.0
- 007
- ta
- 008
- 211013s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/femsyr/foaa020 $2 doi
- 035 __
- $a (PubMed)32324227
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Vaňková, Eva $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 542/2, 166 10, Prague, Czech Republic $u University of Chemistry and Technology Prague, Technická 5, 166 28, Prague, Czech Republic
- 245 10
- $a Combined effect of lasioglossin LL-III derivative with azoles against Candida albicans virulence factors: biofilm formation, phospholipases, proteases and hemolytic activity / $c E. Vaňková, P. Kašparová, N. Dulíčková, V. Čeřovský
- 520 9_
- $a Candida albicans has several virulence factors at its disposal, including yeast-hyphal transition associated with biofilm formation, phospholipases, proteases and hemolytic activity, all of which contribute to its pathogenesis. We used synthetic derivative LL-III/43 of antimicrobial peptide lasioglossin LL-III to enhance effect of azoles on attenuation of C. albicans virulence factors. LL-III/43 was able to inhibit initial adhesion or biofilm formation of C. albicans strains at 50 µM. Azoles, however, were ineffective at this concentration. Using fluorescently labeled LL-III/43, we observed that peptide covered C. albicans cells, partially penetrated through their membranes and then accumulated inside cells. LL-III/43 (25 µM) in combination with clotrimazole prevented biofilm formation already at 3.1 µM clotrimazole. Neither LL-III/43 nor azoles were able to significantly inhibit phospholipases, proteases, or hemolytic activity of C. albicans. LL-III/43 (25 µM) and clotrimazole (50 µM) in combination decreased production of these virulence factors, and it completely attenuated its hemolytic activity. Scanning electron microscopy showed that LL-III/43 (50 µM) prevented C. albicans biofilm formation on Ti-6Al-4 V alloy used in orthopedic surgeries and combination of LL-III/43 (25 µM) with clotrimazole (3.1 µM) prevented biofilm formation on urinary catheters. Therefore, mixture of LL-III/43 and clotrimazole is suitable candidate for future pharmaceutical research.
- 650 _2
- $a antifungální látky $x farmakologie $7 D000935
- 650 _2
- $a kationické antimikrobiální peptidy $x chemická syntéza $x farmakokinetika $7 D023181
- 650 _2
- $a azoly $x farmakologie $7 D001393
- 650 _2
- $a biofilmy $x účinky léků $x růst a vývoj $7 D018441
- 650 _2
- $a Candida albicans $x účinky léků $7 D002176
- 650 _2
- $a erytrocyty $x účinky léků $7 D004912
- 650 _2
- $a hemolýza $x účinky léků $7 D006461
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hydrofobní a hydrofilní interakce $x účinky léků $7 D057927
- 650 _2
- $a proteasy $x metabolismus $7 D010447
- 650 _2
- $a fosfolipasy $x antagonisté a inhibitory $7 D010740
- 650 _2
- $a faktory virulence $7 D037521
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kašparová, Petra $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 542/2, 166 10, Prague, Czech Republic $u University of Chemistry and Technology Prague, Technická 5, 166 28, Prague, Czech Republic
- 700 1_
- $a Dulíčková, Nikola $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 542/2, 166 10, Prague, Czech Republic $u University of Chemistry and Technology Prague, Technická 5, 166 28, Prague, Czech Republic
- 700 1_
- $a Čeřovský, Václav $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo náměstí 542/2, 166 10, Prague, Czech Republic
- 773 0_
- $w MED00006483 $t FEMS yeast research $x 1567-1364 $g Roč. 20, č. 3 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32324227 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026132706 $b ABA008
- 999 __
- $a ok $b bmc $g 1715450 $s 1147220
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 20 $c 3 $e 20200501 $i 1567-1364 $m FEMS yeast research $n FEMS Yeast Res $x MED00006483
- GRA __
- $a NV16-27726A $p MZ0
- LZP __
- $a Pubmed-20211013